EUVIMEDEUVIMED entdecken
Crossref

Drugs for Hypothyroidism

The Medical Letter on Drugs and Therapeutics · 2023

DOI: 10.58347/tml.2023.1670a ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, 2023. Hauptthemen laut MEDLINE: Hypothyroidism. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary hypothyroidism is usually the result of Hashimoto's (autoimmune) thyroiditis, thyroidectomy, or radioactive iodine therapy. Treatment of hypothyroidism with replacement doses of thyroid hormone is usually lifelong. Levothyroxine (LT4; synthetic thyroxine; Synthroid, and others) is the drug of choice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypothyroidismHumansHormone Replacement TherapyThyroxine

Stichwörter der Autor:innen

Armour ThyroidCytomelEuthyroxLevo-TLevoxylNP ThyroidSynthroidThyquidityTirosintUnithroidadverse effectsdosagedrug interactionsefficacyhypothyroidism

Substanzen

Thyroxine

Zitieren

APA

(2023). Drugs for Hypothyroidism. The Medical Letter on Drugs and Therapeutics. https://doi.org/10.58347/tml.2023.1670a

Vancouver

Drugs for Hypothyroidism. The Medical Letter on Drugs and Therapeutics. 2023. doi:10.58347/tml.2023.1670a

BibTeX
@article{euvimed2023,
  title = {Drugs for Hypothyroidism},
  journal = {The Medical Letter on Drugs and Therapeutics},
  year = {2023},
  doi = {10.58347/tml.2023.1670a}
}
Kostenlos starten →